A long-range interactive DNA methylation marker panel for the promoters of HOXA9 and HOXA10 predicts survival in breast cancer patients.

Clin Epigenetics · 2017 · PMC5525292 · PMID 28748001

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The initial selection was performed based on the Δ β value, and the combination of the six HOXA9 and HOXA10 promoter methylation markers showed a highly significant prognostic value.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.